Lincare Holdings, a home respiratory company, announced last week that it had received subpoenas from the U.S. attorney's office in Sacramento, Calif., for documents involving its operations in two states.
The subpoenas seek documents related to the provision of home oxygen therapy to Medicare and Medicaid beneficiaries in 1995 and 1996 at five Lincare locations in California and Oregon.
In addition, the U.S. attorney's office sought documents on marketing programs and practices for oxygen and other therapies, and certain policies and procedures at the Lincare centers from 1995 to the present.
Lincare, based in Clearwater, Fla., received the subpoenas in mid-June and is cooperating with the investigation, company officials said. Lincare, which provides oxygen and respiratory therapy services and equipment to more than 150,000 patients in 40 states, will turn over the first set of documents by the end of this month, said Angela Bryant, corporate counsel.
The company denies wrongdoing.
The U.S. attorney's office confirmed its ongoing investigation of Lincare but would not comment on specifics of the case.
A spokesman also declined to comment on whether the case was part of a broader probe of home-care practices in the region. Earlier this month, Apria Healthcare Group, a Costa Mesa, Calif.-based home-care company, announced it had received six subpoenas from the same U.S. attorney's office that requested documents related to the company's billing practices.